Supply Chain Intelligence

AbbVie Inc. Supply Chain

ABBV supply chain intelligence for AbbVie Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

ABBV ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

5Suppliers
8Customers
2Debt Items
20Related Chains

AbbVie Inc. Suppliers

TickerNameConfidenceEvidence
IRWD Ironwood Pharmaceuticals, Inc. 92% Reciprocal relationship from IRWD graph: The Company records royalties on sales of CONSTELLA in Canada and LINZESS in Mexico in the period earned.
XLO Xilio Therapeutics, Inc. 92% Reciprocal relationship from XLO graph: upfront and milestone payments under our collaboration and license agreements with AbbVie
ALDX Aldeyra Therapeutics, Inc. 90% Reciprocal relationship from ALDX graph: Reciprocal relationship from ABBV graph: Reciprocal relationship from ALDX graph: Outside of the United States, the Company would be eligible to receive tiere…
IMNM Immunome, Inc. 85% Reciprocal relationship from IMNM graph: Reciprocal relationship from ABBV graph: Reciprocal relationship from IMNM graph: generated any revenue from product sales and do not expect to do so for the …
CTMX CytomX Therapeutics, Inc. 80% Reciprocal relationship from CTMX graph: For instance, in March 2023, AbbVie terminated our 2016 CD71 License and Collaboration Agreement

AbbVie Inc. Customers

TickerNameConfidenceEvidence
IRON Disc Medicine, Inc. 92% Reciprocal relationship from IRON graph: Under the AbbVie Agreement, we obtained an exclusive, worldwide license, with the right to sublicense to commercial pharmaceutical and biopharmaceutical compa…
U-S-WHOLESALERS U-S-WHOLESALERS 92% three U.S. wholesalers accounted for 78 % as of March 31, 2026 and 84 % as of December 31, 2025, and substantially all of AbbVie’s pharmaceutical product net revenues in the United States were to the…
SION Sionna Therapeutics, Inc. 90% Reciprocal relationship from SION graph: Reciprocal relationship from ABBV graph: Reciprocal relationship from SION graph: Reciprocal relationship from ABBV graph: Reciprocal relationship from SION g…
JANSSEN-BIOTECH-INC JANSSEN-BIOTECH-INC 85% ended March 31, 2026 and $ 242 million for the three months ended March 31, 2025. Sales and marketing and development costs for the three months ended March 31, 2026 and 2025 were insignificant. Coll…
JNJ Johnson & Johnson 85% Reciprocal relationship from JNJ graph: Reciprocal relationship from ABBV graph: ended March 31, 2026 and $ 242 million for the three months ended March 31, 2025. Sales and marketing and development …
ROCHE-GROUP ROCHE-GROUP 85% rs. The upfront payment of $ 650 million was recorded in acquired IPR&D and milestones expense in the condensed consolidated statement of earnings in the first quarter of 2026. AbbVie could make addi…
ARGX argenx SE 80% Reciprocal relationship from ARGX graph: We currently have collaborative research relationships with various pharmaceutical companies such as AbbVie
CTMX CytomX Therapeutics, Inc. 80% Reciprocal relationship from CTMX graph: For instance, in March 2023, AbbVie terminated our 2016 CD71 License and Collaboration Agreement, and from time to time some of our research programs have bee…

AbbVie Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ABBV-DEBT Debt stack $72.9B 90% Market cache reports total debt of $72.9B.
ABBV-DEBT-39463 Debt 90% debt detail from 424B5 2026-02-26.

AbbVie Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for AbbVie Inc..

AbbVie Inc. Ownership

HolderNameConfidenceEvidence
ABBV-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 4080 tracked holders.

AbbVie Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ADGM Adagio Medical Holdings, Inc. 100.00 2
TRIB Trinity Biotech plc 100.00 2
CLGN CollPlant Biotechnologies Ltd. 100.00 2
SNNUF Smith & Nephew plc 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
ALC Alcon Inc. 100.00 2
ATRA Atara Biotherapeutics, Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
ALDX Aldeyra Therapeutics, Inc. 100.00 1 ['supplier']
BNR Burning Rock Biotech Limited 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
AMGN Amgen Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
BLLN BillionToOne, Inc. 100.00 2
CSTE Caesarstone Ltd. 100.00 2
AORT Artivion, Inc. 100.00 2
HTGC Hercules Capital, Inc. 100.00 2
ACIU AC Immune SA 100.00 2
View ABBV supply chain intel →

Explore the full interactive supply chain map for AbbVie Inc..

Open ABBV supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map